Although cannabis research seems to be largely focused on CBD and THC at the moment, a recent study emerged that examined the anti-inflammatory effects of two flavonoids.
Also, doctors continue to prescribe synthetic Marinol, despite numerous complains from patients stating that real cannabis is more effective and leaves them with less side-effects. And did you know that CBD could possibly be used to treat gum disease? All that and more in this week’s Medical Cannabis Weekly Review and Newsletter.
Despite the fact that most of the United States has legalized some form of medical cannabis or CBD, many doctors are still urging patients to use a synthetic alternative instead. Marinol, generic Dronabinol, is the first FDA-approved, cannabinoid substitute. It’s sold as a gel capsule and it contains a man-made form of THC as the active ingredient.
While most of today’s medical research has focused on the benefits CBD and THC, a recent study explored a couple of lesser known compounds. The research, which was published in the journal Phytochemistry, revealed that two flavonoids, cannflavin A and cannflavin B, have extremely powerful anti-inflammatory effects – 30 times more potent than OTC drug Aspirin.
CBD contains anti-bacterial properties and is believed to be useful in the treatment of gum diseases such as Gingivitis and Periodontitis. Australian based medical cannabis company, Impression Healthcare, has just been approved for a Phase 2a Clinical Trial looking at how CBD mouthwash and toothpaste could be used to improve gum health.
In another disturbing news headline for the vaping industry, health officials in Wisconsin are reporting at least eight cases of “severe lung damage” among teens, believed to be caused by vaping E-cigarettes. Doctors from the Children’s Hospital of Wisconsin reported their findings to the Department of Health Services earlier in July.
OTHER TRENDING NEWS
In a warning letter dated July 22, 2019, The FDA addressed multiple violations being committed by the company CuraLeaf. Does that name sound familiar to you? It should. It’s the company that secured a deal with CVS to sell CBD products in the pharmacy chain earlier this year. In the letter, the FDA referred to CuraLeaf products as “unapproved and misbranded human drugs products.”
LIMITED-TIME OFFER. For people who need instant relief from their pain, insomnia, or anxiety, vaping CBD can be the ultimate solution. Vaping is believed to be safer than smoking and works faster than edibles. When you come across such a high quality product as the PhenoPen, it’s a no-brainer.